News
Important Only
Other
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy
June 17 (Reuters) - Incannex Healthcare Inc IXHL.O:INCANNEX HEALTHCARE FORMS JOINT VENTURE WITH MIND MEDICINE AUSTRALIA TO EXPAND ACCESS TO PSYCHEDELIC-ASSISTED THERAPYINCANNEX HEALTHCARE INC - NEW ENTITY MIND MEDICINE AUSTRALIA CLINICS ANNOUNCEDINCANNEX HEALTHCARE INC - PATIENT INTAKE TO BEGIN SHOR...Reuters
Tue, Jun 17
Other
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart™ Test In Detecting Esophageal Cancer
June 17 (Reuters) - Prophase Labs Inc PRPH.O:PROPHASE LABS ANNOUNCES SUCCESSFUL STUDY DEMONSTRATING PERFORMANCE OF BE-SMART™ TEST IN DETECTING ESOPHAGEAL CANCERPROPHASE LABS INC - TO COMMERCIALIZE BE-SMART WITHIN NEXT 2-3 QUARTERSReuters
Tue, Jun 17
Other
Sword Health Raises $40 Million At A $4 Billion Valuation
June 17 (Reuters) - SWORD HEALTH RAISES $40 MILLION AT A $4 BILLION VALUATION AND UNVEILS ALWAYS-ON AI MENTAL HEALTH SOLUTION TO ADDRESS THE GLOBAL MENTAL HEALTH CRISISSWORD HEALTH: FUNDING ROUND LED BY GENERAL CATALYSTSWORD HEALTH: KHOSLA VENTURES, COMCAST VENTURES, LINCE CAPITAL, OXY CAPITAL, ARMI...Reuters
Tue, Jun 17
Stocks
Where Will XRP (Ripple) Be in 1 Year?
Cryptocurrencies are often polarizing. True believers often dismiss any legitimate skepticism of a digital token and its blockchain, while financial traditionalists often can't imagine that any new financial process could take root in an established system.No matter where you fall on this spectrum, ...The Motley Fool
Tue, Jun 17
Stocks
Purecycle Technologies Enters Into Binding Subscription Agreements - SEC Filing
June 17 (Reuters) - Purecycle Technologies Inc PCT.O:PURECYCLE TECHNOLOGIES INC - ENTERS INTO BINDING SUBSCRIPTION AGREEMENTS - SEC FILINGPURECYCLE TECHNOLOGIES INC - TO SELL 300,000 SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK - SEC FILINGPURECYCLE TECHNOLOGIES INC - GROSS PROCEEDS FROM OFFERING ...Reuters
Tue, Jun 17
Other
TDG Gold Announces Acquisition Of Anyox Copper And C$25 Million Bought Deal Private Placement
June 17 (Reuters) - TDG Gold Corp TDG.V:TDG GOLD ANNOUNCES ACQUISITION OF ANYOX COPPER AND C$25 MILLION BOUGHT DEAL PRIVATE PLACEMENTTDG GOLD CORP - TO BUY ALL SECURITIES OF ANYOXTDG GOLD CORP - ANYOX SHAREHOLDERS TO HOLD 20% OF TDG POST-DEALReuters
Tue, Jun 17
Other
Kirkland's To Consolidate To About 290 Store Locations
June 17 (Reuters) - Kirkland's Inc KIRK.O:KIRKLAND'S INC - COMPANY TO CONSOLIDATE TO ABOUT 290 STORE LOCATIONSKIRKLAND'S INC - TO REBRAND AS THE BRAND HOUSE COLLECTIVEKIRKLAND'S INC - TICKER SYMBOL TO CHANGE FROM 'KIRK' TO 'TBHC'Reuters
Tue, Jun 17
Other
Vireo Growth Provides Corporate Update Post Closing Of All Merger Transactions
June 17 (Reuters) - Vireo Growth Inc VREO.CD:VIREO GROWTH INC. PROVIDES CORPORATE UPDATE POST CLOSING OF ALL MERGER TRANSACTIONSVIREO GROWTH INC - EXPECTS Q2 2025 PRO-FORMA REVENUE OF $88-$91 MILLION, ADJUSTED EBITDA OF $23-$24 MILLIONVIREO GROWTH INC - EXPECTS IMPROVED PROFITABILITY TO SECURE BETTE...Reuters
Tue, Jun 17
Other
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application For The Treatment Of Dry Eye Disease
June 17 (Reuters) - Aldeyra Therapeutics Inc ALDX.O:ALDEYRA THERAPEUTICS RESUBMITS REPROXALAP NEW DRUG APPLICATION FOR THE TREATMENT OF DRY EYE DISEASEALDEYRA THERAPEUTICS INC - NO SAFETY CONCERNS IDENTIFIED IN CLINICAL TRIALReuters
Tue, Jun 17
Other
Israel has Iran's military leadership on the run, military official says
JERUSALEM, June 17 (Reuters) - Israel struck dozens of targets linked to Iran's nuclear and ballistic missile programmes overnight and has got Iran's military leadership "on the run", an Israeli military official said on Tuesday.The official, speaking on condition of anonymity, confi...Reuters
Tue, Jun 17
Other
Unicycive Therapeutics Announces Reverse Stock Split
June 17 (Reuters) - Unicycive Therapeutics Inc UNCY.O:UNICYCIVE THERAPEUTICS, INC. ANNOUNCES REVERSE STOCK SPLITUNICYCIVE THERAPEUTICS INC - TO IMPLEMENT 1-FOR-10 REVERSE STOCK SPLITUNICYCIVE THERAPEUTICS INC - COMMON STOCK TO TRADE ON SPLIT-ADJUSTED BASIS FROM JUNE 20UNICYCIVE THERAPEUTICS INC - RE...Reuters
Tue, Jun 17
Commodities
World oil demand to keep growing this decade despite 2027 China peak, IEA says
IEA forecasts oil demand peak at 105.6 million bpd by 2029China's oil demand to peak in 2027 due to EV growthUS demand boosted by lower gasoline prices, slower EV adoptionIEA sharply cuts prediction for US EV adoption in 2030 By Alex Lawler and Enes Tunagur LONDON, June 17 (Reuters) - Global ...Reuters
Tue, Jun 17
Other
Koryx Copper Provides Project Development Update For The Haib Copper Project, Southern Namibia
June 17 (Reuters) - Koryx Copper Inc KRY.V:KORYX COPPER PROVIDES PROJECT DEVELOPMENT UPDATE FOR THE HAIB COPPER PROJECT, SOUTHERN NAMIBIAKORYX COPPER INC - TO PUBLISH PEA FOR HAIB COPPER PROJECT IN Q3 2025KORYX COPPER INC - COMMENCES COLUMN LEACH TESTS, RESULTS EXPECTED EARLY 2026Reuters
Tue, Jun 17
Other
Purple Biotech Announces Initiation Of Phase 2 Study Of Nt219 In Patients With Head And Neck Cancer
June 17 (Reuters) - Purple Biotech Ltd PPBT.TA:PURPLE BIOTECH ANNOUNCES INITIATION OF PHASE 2 STUDY OF NT219 IN PATIENTS WITH HEAD AND NECK CANCERPURPLE BIOTECH LTD - STUDY TO BEGIN WITH 10 PATIENTS PER ARM, EXPAND TO 29Reuters
Tue, Jun 17
Stocks
Should You Buy Tesla Stock While It's Below $350?
At the start of this year, Tesla (NASDAQ: TSLA) had a share price of $428, but as CEO Elon Musk spent more and more time working for the Trump administration running the Department of Government Efficiency (DOGE) and less time at his automotive company, Tesla's stock began faltering.It's regained so...The Motley Fool
Tue, Jun 17
Other
Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson’S Disease
June 17 (Reuters) - Ventyx Biosciences Inc VTYX.O:VENTYX BIOSCIENCES ANNOUNCES POSITIVE TOP-LINE DATA FROM ITS PHASE 2A SAFETY AND BIOMARKER TRIAL EVALUATING VTX3232 IN PATIENTS WITH EARLY-STAGE PARKINSON’S DISEASEVENTYX BIOSCIENCES INC - VTX3232 STUDY MEETS PRIMARY GOAL OF SAFETY AND TOLERABILITYVE...Reuters
Tue, Jun 17
Stocks
Citi starts Novavax with "sell/high risk" rating on shrinking vaccine market
** Brokerage Citi Research starts coverage on vaccine maker Novavax NVAX.O with "sell/high risk" rating and $6 PT** PT represents a near 15% downside to the stock's last close** Brokerage says Novavax is too focused on respiratory vaccines, a market that's seeing declining vaccinatio...Reuters
Tue, Jun 17
